OncoTherapy Science, Inc.
Develops targeted cancer therapies and provides TCR repertoire analysis services.
4564 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 川崎市川崎区東田町１番地２
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
OncoTherapy Science, Inc. is a biotechnology company focused on the research and development of novel cancer treatments. Founded in 2001, the company collaborates with genomics pioneer Professor Yusuke Nakamura to identify cancer-specific genes for the creation of molecular-targeted therapies, including low-molecular-weight drugs and antibody drugs. The company's mission is to develop treatments with high efficacy and minimal adverse events. In addition to its drug discovery pipeline, OncoTherapy Science offers a comprehensive T-cell receptor (TCR) repertoire analysis service, utilizing next-generation sequencing technology for detailed immunoprofiling from blood and tissue samples.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for OncoTherapy Science, Inc. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-26 03:49 |
Regulatory News Service
臨時報告書
|
Japanese | 21.9 KB | |
| 2025-06-24 09:11 |
Regulatory News Service
内部統制報告書－第24期(2024/04/01－2025/03/31)
|
Japanese | 22.8 KB | |
| 2025-06-24 09:10 |
Regulatory News Service
確認書
|
Japanese | 8.2 KB | |
| 2025-06-24 09:09 |
Annual Report
有価証券報告書－第24期(2024/04/01－2025/03/31)
|
Japanese | 976.0 KB | |
| 2025-04-10 08:33 |
Prospectus
有価証券届出書（組込方式）
|
Japanese | 404.8 KB | |
| 2025-02-18 01:06 |
Regulatory News Service
臨時報告書
|
Japanese | 21.4 KB | |
| 2024-11-11 01:25 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-11-11 01:23 |
Interim Report
半期報告書－第24期(2024/04/01－2025/03/31)
|
Japanese | 272.5 KB | |
| 2024-06-28 08:58 |
Regulatory News Service
臨時報告書
|
Japanese | 22.8 KB | |
| 2024-06-25 09:30 |
Regulatory News Service
内部統制報告書－第23期(2023/04/01－2024/03/31)
|
Japanese | 22.9 KB | |
| 2024-06-25 09:29 |
Regulatory News Service
確認書
|
Japanese | 8.2 KB | |
| 2024-06-25 09:26 |
Annual Report
有価証券報告書－第23期(2023/04/01－2024/03/31)
|
Japanese | 1007.8 KB | |
| 2024-04-05 08:07 |
Prospectus
有価証券届出書（組込方式）
|
Japanese | 368.3 KB | |
| 2024-02-16 08:53 |
Regulatory News Service
臨時報告書
|
Japanese | 22.1 KB | |
| 2024-02-13 01:17 |
Regulatory News Service
確認書
|
Japanese | 8.2 KB |
Automate Your Workflow. Get a real-time feed of all OncoTherapy Science, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for OncoTherapy Science, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
%20Co.%2C%20Ltd/other/SLSBioSpecialty_Lab_Solution_Bio_Co._Ltd-logo.jpg){kind=logo}
